Search - tctmd.com

Displaying 41 - 60 of 68

Sort: Relevancy | Date

New HF Guidelines Stress Four Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 01, 2022

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

News Daily News

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Yael L. Maxwell

February 24, 2022

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

News Daily News

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

February 10, 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

Modified Surgical MV Repair Stands Up to Replacement

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Women Less Likely Than Men to Experience SCD During Sports

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

November 16, 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

May 15, 2021

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

December 17, 2020

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

November 02, 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

News Conference News HRS 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

May 13, 2020

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

News Daily News

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

May 11, 2020

Cancer Survivors With Heart Failure Respond Well to CRT

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

May 14, 2019

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

Presentation ECHO 2018

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

Presenter: Gerard P. Aurigemma

April 19, 2018

Hypertrophic Cardiomyopathy

Presentation ECHO 2018

Hypertrophic Cardiomyopathy

Presenter: Muhamed Sarić

April 19, 2018

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

News Daily News

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

March 06, 2018

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.